Condition: Non Small Cell Lung Cancer · Healthy · Sponsor: OncoHost Ltd.
The goal of this exploratory study is understand the mechanisms of response to immunotherapy in Non-Small Cell Lung Cancer patients. The investigators are going to search for correlation between specific biological features and response to immunotherapy, and to use those associations for developing an algorithm enabling to identify patients that could benefit from the immune check inhibitor based anti cancer treatment. Patients will provide biological samples before and during their treatment, and clinical data will be collected.
This description comes directly from the study's public registry record.
Galit Yahalom, PhD · 97248537557 · galit@oncohost.com
Shani Raveh Shoval, PhD · 97248537557 · shani@oncohost.com
Always discuss trial participation with your own doctor first.
| Baylor Scott and White Research Institute | Dallas, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05736029